RYTM
Rhythm Pharmaceuticals Inc
98.20$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +8,911.4% | +649.5% | +227.6% | +68.1% | +45.8% | |
| – | – | – | +54.9% | +98.2% | +88.7% | -17.3% | -13.2% | +256.1% | +336.1% | +43.7% | +45.8% | |
| – | – | – | – | – | – | – | – | +741.7% | +216.8% | +71.4% | +45.8% | |
| – | +35.4% | +174.1% | +16.8% | +119.9% | +117.4% | -17.4% | +15.1% | +4.3% | +24.2% | +76.3% | -29.7% | |
| – | +182.4% | +84.3% | +50.8% | +195.0% | +30.2% | +26.2% | +48.5% | +34.4% | +21.1% | +29.4% | +35.1% | |
| – | +62.8% | +145.0% | +25.1% | +141.9% | +86.2% | -6.5% | +26.4% | +16.2% | +25.8% | +51.4% | -5.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -94.8% | +167.1% | +48.3% | -0.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +305.3% | -240.2% | – | – | – | -71.3% | -38.7% | +43.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.